When tight is too tight

Dasatinib and its lower affinity analogue for profiling kinase inhibitors in a three-hybrid split-luciferase system

Luca O. Ogunleye, Benjamin W. Jester, Alexander J. Riemen, Ahmed H. Badran, Ping Wang, Indraneel Ghosh

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The development of methods for profiling inhibitors of protein kinases has seen tremendous progress over the last decade. We have previously reported a split-luciferase based three-hybrid approach for determining kinase inhibitor selectivity that utilized the promiscuous staurosporine warhead for designing chemical inducers of dimerization (CID). Herein we describe the extension of this methodology to target the tyrosine kinase (TK) group using a Dasatinib warhead based CID. We found that though the Dasatinib enabled CID provided a means for assembling the split-protein fragments, it had too tight an affinity in the context of the three-hybrid system for several TKs and could not be displaced with inhibitors. By tuning the affinity of Dasatinib, we were able to successfully target multiple TKs that could subsequently be assayed for inhibition by small molecules. We further demonstrated that the new CID allowed for the screening and identification of inhibitors against ABL.

Original languageEnglish (US)
Pages (from-to)328-332
Number of pages5
JournalMedChemComm
Volume5
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Dimerization
Luciferases
Phosphotransferases
Staurosporine
Protein Kinase Inhibitors
Hybrid systems
Protein-Tyrosine Kinases
Screening
Tuning
Molecules
Dasatinib
Proteins

ASJC Scopus subject areas

  • Biochemistry
  • Pharmaceutical Science

Cite this

When tight is too tight : Dasatinib and its lower affinity analogue for profiling kinase inhibitors in a three-hybrid split-luciferase system. / Ogunleye, Luca O.; Jester, Benjamin W.; Riemen, Alexander J.; Badran, Ahmed H.; Wang, Ping; Ghosh, Indraneel.

In: MedChemComm, Vol. 5, No. 3, 2014, p. 328-332.

Research output: Contribution to journalArticle

Ogunleye, Luca O. ; Jester, Benjamin W. ; Riemen, Alexander J. ; Badran, Ahmed H. ; Wang, Ping ; Ghosh, Indraneel. / When tight is too tight : Dasatinib and its lower affinity analogue for profiling kinase inhibitors in a three-hybrid split-luciferase system. In: MedChemComm. 2014 ; Vol. 5, No. 3. pp. 328-332.
@article{6ae2c13ae33d481ca2608eebbb42e487,
title = "When tight is too tight: Dasatinib and its lower affinity analogue for profiling kinase inhibitors in a three-hybrid split-luciferase system",
abstract = "The development of methods for profiling inhibitors of protein kinases has seen tremendous progress over the last decade. We have previously reported a split-luciferase based three-hybrid approach for determining kinase inhibitor selectivity that utilized the promiscuous staurosporine warhead for designing chemical inducers of dimerization (CID). Herein we describe the extension of this methodology to target the tyrosine kinase (TK) group using a Dasatinib warhead based CID. We found that though the Dasatinib enabled CID provided a means for assembling the split-protein fragments, it had too tight an affinity in the context of the three-hybrid system for several TKs and could not be displaced with inhibitors. By tuning the affinity of Dasatinib, we were able to successfully target multiple TKs that could subsequently be assayed for inhibition by small molecules. We further demonstrated that the new CID allowed for the screening and identification of inhibitors against ABL.",
author = "Ogunleye, {Luca O.} and Jester, {Benjamin W.} and Riemen, {Alexander J.} and Badran, {Ahmed H.} and Ping Wang and Indraneel Ghosh",
year = "2014",
doi = "10.1039/c3md00275f",
language = "English (US)",
volume = "5",
pages = "328--332",
journal = "MedChemComm",
issn = "2040-2503",
publisher = "Royal Society of Chemistry",
number = "3",

}

TY - JOUR

T1 - When tight is too tight

T2 - Dasatinib and its lower affinity analogue for profiling kinase inhibitors in a three-hybrid split-luciferase system

AU - Ogunleye, Luca O.

AU - Jester, Benjamin W.

AU - Riemen, Alexander J.

AU - Badran, Ahmed H.

AU - Wang, Ping

AU - Ghosh, Indraneel

PY - 2014

Y1 - 2014

N2 - The development of methods for profiling inhibitors of protein kinases has seen tremendous progress over the last decade. We have previously reported a split-luciferase based three-hybrid approach for determining kinase inhibitor selectivity that utilized the promiscuous staurosporine warhead for designing chemical inducers of dimerization (CID). Herein we describe the extension of this methodology to target the tyrosine kinase (TK) group using a Dasatinib warhead based CID. We found that though the Dasatinib enabled CID provided a means for assembling the split-protein fragments, it had too tight an affinity in the context of the three-hybrid system for several TKs and could not be displaced with inhibitors. By tuning the affinity of Dasatinib, we were able to successfully target multiple TKs that could subsequently be assayed for inhibition by small molecules. We further demonstrated that the new CID allowed for the screening and identification of inhibitors against ABL.

AB - The development of methods for profiling inhibitors of protein kinases has seen tremendous progress over the last decade. We have previously reported a split-luciferase based three-hybrid approach for determining kinase inhibitor selectivity that utilized the promiscuous staurosporine warhead for designing chemical inducers of dimerization (CID). Herein we describe the extension of this methodology to target the tyrosine kinase (TK) group using a Dasatinib warhead based CID. We found that though the Dasatinib enabled CID provided a means for assembling the split-protein fragments, it had too tight an affinity in the context of the three-hybrid system for several TKs and could not be displaced with inhibitors. By tuning the affinity of Dasatinib, we were able to successfully target multiple TKs that could subsequently be assayed for inhibition by small molecules. We further demonstrated that the new CID allowed for the screening and identification of inhibitors against ABL.

UR - http://www.scopus.com/inward/record.url?scp=84895145739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895145739&partnerID=8YFLogxK

U2 - 10.1039/c3md00275f

DO - 10.1039/c3md00275f

M3 - Article

VL - 5

SP - 328

EP - 332

JO - MedChemComm

JF - MedChemComm

SN - 2040-2503

IS - 3

ER -